Buscar
01/01/2025
Anatomical and functional results of plasma rich in growth factors as a treatment for poor-prognosis macular holes.
Caminal-Caramés M, Vilimelis JC, Quinto CO, Pernias AS, Conversa S, Reyes AV, Cascajosa JD, Lorca DR, Pérez MPP, Segarra JIV. Anatomical and functional results of plasma rich in growth factors as a treatment for poor-prognosis macular holes.. Romanian Journal Of Ophthalmology. 2025; 69(4)DOI:10.22336/rjo.2025.81. PMID:41971203. IF:(Q/D).
01/05/2024
Sensitisation to textile dyes in Spain: Epidemiological situation (2019-2022)
Fernández, CPH, Borrego, L, Arnau, AMG, Ninet, VZ, Sánchez, TS, Miquel, FJM, Pérez, RG, Salvador, JFS, Guijarro, SC, Carrillo, JMC, Ortega, MEG, González, IR, García, PM, Romero, FT, Baldrich, ES, Pastor-Nieto, MA, Serna, MR, Pérez, JS, Gilo, AS, Ninot, GM, Guillén, PSP, Martínez, MD, Descalzo, MAG, Doval, IG. Sensitisation to textile dyes in Spain: Epidemiological situation (2019-2022). CONTACT DERMATITIS. 2024; 90(5)DOI:10.1111/cod.14513. PMID:. IF:4.600(Q1/1D).
01/03/2026
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors
Blauvelt, A, Strober, BE, Eakin, GS, Howard, LM, Langan, C, van de Kerkhof, PCM, Puig, L, Lebwohl, MG, Romiti, R, Armstrong, AW, Choon, SE, Ramessur, R, Gelfand, JM, Merola, JF, Winthrop, KL, Torres, T. Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2026; 94(3)DOI:10.1016/j.jaad.2025.11.033. PMID:41260526. IF:11.800(Q1/1D).
01/04/2026
Disease Burden and Treatment Patterns in Patients With Hidradenitis Suppurativa and Concomitant Arthritis: A Multicenter Case-Control Study
Garbayo-Salmons, P, Molina-Leyva, A, Porta-Vilaró, A, Soto-Moreno, A, Fornons-Servent, R, Gamissans, M, Garcias-Ladaria, J, Gracia-Darder, I, Martin-Ezquerra, G, Verdaguer-Faja, J, Mora-Fernández, V, Aguayo-Ortiz, RS, Vilarrasa, E, Masferrer, E, Corral-Magaña, O, Galvany, L, Rodrigo-Parés, A, Saus, E, Moreno, M, Carreras, A, Feliu-Hernàndez, C, Exposito-Serrano, V, Ribera, M, Sabat, M, Calvet, J. Disease Burden and Treatment Patterns in Patients With Hidradenitis Suppurativa and Concomitant Arthritis: A Multicenter Case-Control Study. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(4)DOI:10.1111/ijd.70125. PMID:41164894. IF:3.200(Q1/3D).
01/02/2026
Effectiveness of 12-months tralokinumab treatment in 124 adults with atopic dermatitis with genital involvement: final real-world data from the prospective, non-interventional, international, single-cohort trace study
Krüger-Szabo, A, Ameen, A, Serra-Baldrich, E, Armstrong, AW, Festini, T, Vinther, F, Vittrup, I, Wiseman, MC. Effectiveness of 12-months tralokinumab treatment in 124 adults with atopic dermatitis with genital involvement: final real-world data from the prospective, non-interventional, international, single-cohort trace study. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. 2026; 24DOI:. PMID:. IF:3.800(Q1/2D).
02/03/2026
Validation of performance of Spanish version of PURE-4 questionnaire for early identification of psoriatic arthritis after 1 year of follow-up in patients with psoriasis
Queiro-Silva, R, López-Ferrer, A, Farrés, MFI, Rivera-Díaz, R, Vidal-Sarro, D, Fernández-Freire, LR, de la Cueva-Dobao, P, Santos-Juanes, J, Rocamora-Duran, V, Gómez-Labrador, L, Belinchón-Romero, I. Validation of performance of Spanish version of PURE-4 questionnaire for early identification of psoriatic arthritis after 1 year of follow-up in patients with psoriasis. PLoS One. 2026; 21(3)DOI:10.1371/journal.pone.0342498. PMID:41770732. IF:2.600(Q2/4D).